Psychopharmacology is a dominant treatment in child and adolescent psychiatry with proven benefits to young patients. The authors present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical issues, Treatment planning, Side effects, Neural correlates, and Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES: Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis and Schizophrenia, High-risk for bilpolar and schizophrenia, Bipolar, ADHD, and Autism. Each topic presents an Overview of the Disease or Issue, Empirical evidence for ethical issues, Treatment summaries that include dose ranges, side effects, contraindications, and how the drugs are used specifically for a disorder. Treatment in the presence of co-morbid conditions, Long-term evidence, and Conclusions and Future directions complete the presentations. Clinical vignettes are provided that exemplify the main points of the topic.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 5 6. Better and Safer Pharmacotherapy for Youth with Psychiatric Illness - p. 6 7. Appropriate and Judicious Use of Psychotropic Medications in Youth - p. 7 8. Management of Psychotropic Medication Side Effects in Children and Adolescents - p. 13 9. Interventions for Youth at High Risk for Bipolar Disorder and Schizophrenia - p. 25 10. The Neural Effects of Psychotropic Medications in Children and Adolescents - p. 32 11. Psychiatric Pharmacogenomics in Pediatric Psychopharmacology - p. 42 12. Psychopharmacologic Treatment for Pediatric Anxiety Disorders - p. 51 13. Depression - p. 62 14. Psychopharmacologic Treatment of Obesity and Eating Disorders in Children and Adolescents - p. 74 15. Pediatric Sleep Pharmacology - p. 87 16. Empirical Evidence for Psychopharmacologic Treatment in Early-Onset Psychosis and Schizophrenia - p. 96 17. Pharmacologic Treatment of Bipolar Disorder in Children and Adolescents - p. 107 18. Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder - p. 121 19. Psychopharmacology of Autism Spectrum Disorder - p. 129 20. Index - p. 139
Psychopharmacology is a dominant treatment in child and adolescent psychiatry with proven benefits to young patients. The authors present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical issues, Treatment planning, Side effects, Neural correlates, and Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES: Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis and Schizophrenia, High-risk for bilpolar and schizophrenia, Bipolar, ADHD, and Autism. Each topic presents an Overview of the Disease or Issue, Empirical evidence for ethical issues, Treatment summaries that include dose ranges, side effects, contraindications, and how the drugs are used specifically for a disorder. Treatment in the presence of co-morbid conditions, Long-term evidence, and Conclusions and Future directions complete the presentations. Clinical vignettes are provided that exemplify the main points of the topic.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 5 6. Better and Safer Pharmacotherapy for Youth with Psychiatric Illness - p. 6 7. Appropriate and Judicious Use of Psychotropic Medications in Youth - p. 7 8. Management of Psychotropic Medication Side Effects in Children and Adolescents - p. 13 9. Interventions for Youth at High Risk for Bipolar Disorder and Schizophrenia - p. 25 10. The Neural Effects of Psychotropic Medications in Children and Adolescents - p. 32 11. Psychiatric Pharmacogenomics in Pediatric Psychopharmacology - p. 42 12. Psychopharmacologic Treatment for Pediatric Anxiety Disorders - p. 51 13. Depression - p. 62 14. Psychopharmacologic Treatment of Obesity and Eating Disorders in Children and Adolescents - p. 74 15. Pediatric Sleep Pharmacology - p. 87 16. Empirical Evidence for Psychopharmacologic Treatment in Early-Onset Psychosis and Schizophrenia - p. 96 17. Pharmacologic Treatment of Bipolar Disorder in Children and Adolescents - p. 107 18. Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder - p. 121 19. Psychopharmacology of Autism Spectrum Disorder - p. 129 20. Index - p. 139
